Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection

Nitin Merubhai Mori1, Priya Patel1, Navin R. Sheth2, Lalji V. Rathod3, Kalpesh Chhotalal Ashara4
1Department of Pharmaceutical Science, Saurashtra University, Rajkot 360005, Gujarat, India
2GTU, Ahmedabad, India
3Maharaja Sayajirao University, Vadodara, Gujarat, India
4School of Pharmacy, RK University, Rajkot 360020, Gujarat, India

Tài liệu tham khảo

Sevgi, 2013, New formulation strategies in topical antifungal therapy, J. Cos. Derma Sci. Appl., 3, 56 K.C. Ashara, J.S. Paun, N.M. Mori, J.R. Chavda, M.M. Soniwala, Topical antifungal micro emulged composition and method of preparation thereof, Indian Patents, 3169/MUM/2014 A, 2016. K.C. Ashara, N.M. Mori, N.R. Sheth, Topical antifungal film forming transdermal spray composition and method of preparation thereof. India Patent, 3386/MUM/2014 A, 2016. Scott, 2007, Voriconazole: a review of its use in the management of invasive fungal infections, Drugs, 67, 269, 10.2165/00003495-200767020-00009 Lane, 2013, Skin penetration enhancers, Int. J. Pharm., 447, 12, 10.1016/j.ijpharm.2013.02.040 Vonaz Tab/Inj, in leave behind literature, United Biotech Ltd. 2–6, www.unitetedbiotechindia.com. Access 2013. Kapadia, 2013, Preliminary investigation tests of novel antifungal topical aerosol, J. Pharm. Bio. All. Sci., 4, 74, 10.4103/0975-7406.94145 Bajaj, 2012, A novel meter dose transdermal spray formulation of oxybutynin, Ind. J. Pharm. Sci., 70, 733, 10.4103/0250-474X.49094 Williams, 1991, Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17, 10.1023/A:1015813803205 Highlights of prescribing information of Product leaflet for Vonaz, United Biotech Ltd. 1–8, www.unitetedbiotechindia.com. Access 2013. Parthibarajan, 2012, Formulation and evaluation of voriconazole floating tablets, Asian J. Pharm. Clin. Res., 5, 180 Andonova, 2014, Indomethacin loading and in-vitro release properties from vinyl acetate homo- and copolymer nanoparticles, coated with polyzwitterion and carbopol® shells, Int. J. Pharm. Pharm. Sci., 6, 691 Pal, 1989, Differential thermal analysis, Ind. J. Chem., 28, 55 IIG, FDA. http://www.accessdata.fda.gov/scripts/cder/iig/ getiigweb.cfm. Access 2013. Gohel, 2009, Fabrication of modified transport fluconazole transdermal spray containing Ethyl Cellulose and Eudragit® RS100 as film formers, AAPS PharmSciTech, 10, 684, 10.1208/s12249-009-9256-8 2010 Lawrance, 2008 Lawrance, 2008 Biswal, 2011, Design, development, and evaluation of trimetazidine dihydrochloride modified release tablet using 32 factorial design, Int. Res. J. Pharm. Sci., 2, 56 Patel, 2012 Barry, 2012 Andonova, 2014, Carbopol® and chitosan-coated nanoparticles with in-situ loaded indomethacin, Am. J. PharmTech Res., 4, 664 Csizmazia, 2011 Penkov, 2015, Biological activity of Bulgarian folia betulae dry extract, Int. J. Pharm. Pharma. Sci., 7, 289 G.L. Flynn, Cutaneous and transdermal delivery processes and systems of delivery in Modern Pharmaceutics; ultra deformable and standard liposomes in vitro, in: G.S. Banker, C.T. Rhodes (eds.), 21, fourth ed., USA, Marcel Dekker, 2002, pp. 187–235. El-Maghraby, 2000, Oestradiol skin delivery from ultra deformable liposomes: refinement of surfactant concentration, Int. J. Pharm., 196, 63, 10.1016/S0378-5173(99)00441-X Sathali, 2010, Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride, Int. J. PharmTech Res., 2, 2081 Gupta, 2010, Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis, J. Lipos. Res., 20, 341, 10.3109/08982101003596125 Godin, 2003, Ethosomes new prospects in transdermal delivery, Crit. Rev. Therap. Drug Carr. Syst., 20, 63, 10.1615/CritRevTherDrugCarrierSyst.v20.i1.20 T. Higuchi, Method for in vitro determination of transdermal absorption. US Patent 4771004, 1986. Bamba, 1979, Release mechanism in gel forming sustained release formulation, Int. J. Pharm., 2, 307, 10.1016/0378-5173(79)90037-1 Maebashi, 1994, A novel model of cutaneous candidiasis produced in prednisolone-treated guinea pigs, J. Med. Vet. Mycol., 32, 349, 10.1080/02681219480000471 Basha, 2011, Formulation and evaluation of gel containing fluconazole-antifungal agent, Int. J. Drug Dev. Res., 3, 109 Alkhayat, 2009, The PAS stain for routine diagnosis of Onychomycosis, Bah. Med. Bull., 31, 1 Gupta, 2012, Development, characterization and in-vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis, Chem. Phys. Lip. Sci. Ver. Sci. Direct, 165, 454, 10.1016/j.chemphyslip.2012.01.006 Maghraby, 2008, Liposomes and skin from drug delivery to model membranes, Eur. J. Pharm. Sci., 34, 203, 10.1016/j.ejps.2008.05.002 Ashara, 2016, Microemulgel an overwhelming approach to improve therapeutic action of drug moiety, Saudi Pharm. J., 24, 452, 10.1016/j.jsps.2014.08.002